Charles Ross Carter
Chief Financial Officer · Ovid Therapeutics Inc.
Individual
- 2026
- Jul 8, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Charles Ross Carter files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Margaret A. Alexander - $17K in OVID purchases and sales in the last 12 months
- Jeffrey A. Rona - $12K in OVID purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Charles Ross Carter?
Charles Ross Carter is a corporate insider, tracked as Chief Financial Officer of Ovid Therapeutics Inc. (OVID). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Charles Ross Carter last file a Form 4?
The only primary Form 4 on record is dated 8 July 2026.
